Physician profile
Steven P Johnson
NPI 1710963681
$2,814.37
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $382 · 2021: $642 · 2022: $636 · 2023: $520 · 2024: $14.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $439.10 | 2019-2023 | Proclaim, Eterna |
| Abbvie INC. | $395.34 | 2021-2024 | |
| Nevro Corp. | $237.83 | 2019-2022 | |
| Avanos Medical | $220.06 | 2019-2022 | |
| Medtronic USA, INC. | $211.31 | 2019-2020 | |
| Medtronic, INC. | $181.89 | 2021-2023 | Intellis Adaptivestim |
| Allergan, INC. | $167.65 | 2019-2020 | |
| Pfizer INC. | $121.81 | 2020-2023 | |
| Boston Scientific Corporation | $118.19 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $90.22 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $69.70 | 2021 | |
| Eisai INC. | $68.11 | 2020-2021 | |
| Grt US Holding, INC. | $64.21 | 2021-2022 | |
| Amgen INC. | $63.86 | 2019-2022 | |
| Piramal Critical Care | $63.83 | 2020-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $41.48 | 2022 | |
| Si-Bone, INC. | $40.15 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $37.50 | 2021 | |
| Averitas Pharma INC. | $32.03 | 2023 | Qutenza |
| Tactile Systems Technology INC | $29.26 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $28.31 | 2019-2020 | |
| Lilly USA, LLC | $24.98 | 2023 | Emgality |
| Bioventus LLC | $18.25 | 2019 | |
| Merz Pharmaceuticals, LLC | $18.15 | 2023 | Xeomin |
| Organogenesis INC. | $15.65 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.